Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
UBS
Boehringer Ingelheim
McKesson
Cipla
Novartis
Argus Health
Colorcon
Healthtrust

Generated: October 17, 2017

DrugPatentWatch Database Preview

ERYC Drug Profile

« Back to Dashboard

Which patents cover Eryc, and what generic Eryc alternatives are available?

Eryc is a drug marketed by Parke Davis, Mayne Pharma, Warner Chilcott Llc, Hospira, and Johnson And Johnson. and is included in seven NDAs.

The generic ingredient in ERYC is erythromycin. There are ninety-nine drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the erythromycin profile page.

Summary for Tradename: ERYC

US Patents:0
Applicants:5
NDAs:7
Suppliers / Packagers: see list1
Bulk Api Vendors: see list78
Patent Applications: see list7,998
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ERYC at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis
ERYC
erythromycin
CAPSULE, DELAYED REL PELLETS;ORAL062618-001Sep 25, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Johnson And Johnson
ERYCETTE
erythromycin
SWAB;TOPICAL050594-001Feb 15, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe
Parke Davis
ERYC
erythromycin
CAPSULE, DELAYED REL PELLETS;ORAL062546-001Jul 25, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma
ERYC
erythromycin
CAPSULE, DELAYED REL PELLETS;ORAL050536-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Warner Chilcott Llc
ERYC
erythromycin
CAPSULE, DELAYED REL PELLETS;ORAL062338-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
ERYC SPRINKLES
erythromycin
CAPSULE, DELAYED REL PELLETS;ORAL050593-001Jul 22, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
ERYC 125
erythromycin
CAPSULE, DELAYED REL PELLETS;ORAL062648-001Oct 24, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Fish and Richardson
Fuji
Argus Health
Chubb
UBS
Citi
Cantor Fitzgerald
Moodys
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot